scholarly journals LV305, a dendritic cell-targeting integration-deficient ZVex TM -based lentiviral vector encoding NY-ESO-1, induces potent anti-tumor immune response

2016 ◽  
Vol 3 ◽  
pp. 16010 ◽  
Author(s):  
Tina Chang Albershardt ◽  
David James Campbell ◽  
Andrea Jean Parsons ◽  
Megan Merrill Slough ◽  
Jan ter Meulen ◽  
...  
Keyword(s):  
Immune Response ◽  
Dendritic Cell ◽  
Lentiviral Vector ◽  
Cell Targeting

Therapeutic efficacy of PD1/PDL1 blockade in B16 melanoma is greatly enhanced by immunization with dendritic cell-targeting lentiviral vector and protein vaccine

Vaccine ◽  
2020 ◽  
Vol 38 (17) ◽  
pp. 3369-3377 ◽  
Author(s):  
Tina Chang Albershardt ◽  
Andrea Jean Parsons ◽  
Rebecca Susan Reeves ◽  
Patrick Alexander Flynn ◽  
David James Campbell ◽  
...  
Keyword(s):  
Dendritic Cell ◽  
Therapeutic Efficacy ◽  
Lentiviral Vector ◽  
B16 Melanoma ◽  
Cell Targeting ◽  
Protein Vaccine

scholarly journals Virological and Preclinical Characterization of a Dendritic Cell Targeting, Integration-deficient Lentiviral Vector for Cancer Immunotherapy

2015 ◽  
Vol 38 (2) ◽  
pp. 41-53 ◽  
Author(s):  
Jared M. Odegard ◽  
Brenna Kelley-Clarke ◽  
Semih U. Tareen ◽  
David J. Campbell ◽  
Patrick A. Flynn ◽  
...  
Keyword(s):  
Dendritic Cell ◽  
Cancer Immunotherapy ◽  
Lentiviral Vector ◽  
Cell Targeting
Sign in / Sign up

Export Citation Format

Share Document